Genital Herpes Market Insights, Epidemiology and Market Forecast, 2027 - ResearchAndMarkets.com | Financial Buzz

Genital Herpes Market Insights, Epidemiology and Market Forecast, 2027 – ResearchAndMarkets.com

The “Genital
Herpes – Market Insights, Epidemiology and Market Forecast – 2027”
drug pipelines has been added to ResearchAndMarkets.com’s
offering.

The market of Genital Herpes in 7MM was found to be USD 883 million in
2016.

Genital Herpes- Market Insights, Epidemiology and Market Forecast-2027′
report delivers an in-depth understanding of the disease, historical &
forecasted epidemiology as well as the market trends of Genital Herpes
in the United States, EU5 (Germany, Spain, Italy, France and United
Kingdom), and Japan.

The Genital Herpes epidemiology division provide the insights about
historical and current patient pool and forecasted trend for every 7
major countries. It helps to recognize the causes of current and
forecasted trends by exploring numerous studies and views of key opinion
leaders. This part of The report also provides the diagnosed patient
pool and their trends along with assumptions undertaken.

The current therapeutic market is dominated by the use of anti-viral
therapies including Acyclovir, Famciclovir and Valacyclovir. Since these
drugs have gone off patent the therapeutic market is flooded with their
generic versions. Detailed chapter for upcoming therapies like
Pritelivir (AiCuris.), two therapeutic vaccines VCL-HBOL (Vical) and
GEN-003 (Genocea Biosciences) and M5210B (Maruho) have been covered in
the report.

Key Topics Covered:

1. Key Insights

2. Genital Herpes Market Overview at a Glance

3. Disease Background and Overview: Genital Herpes

4. Epidemiology and Patient Population

5. Country Wise-Epidemiology of Genital Herpes

6. Current Treatment and Medical Practices

7. Unmet Needs

8. Marketed drugs

9. Emerging Drugs

10. Genital Herpes: 7 Major Market Analysis

11. Market Outlook by Country

12. Market Drivers

13. Market Barriers

14. Appendix

15. Capabilities

Companies Mentioned

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/glm66n/genital_herpes?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180622005635/en/